Informations générales (source: ClinicalTrials.gov)
National Cohort of Patients With Cowden's Disease and With a Constitutional Alteration of the PTEN Gene for the Prospective Assessment of the Risk of Cancer.
Observational
Institut Bergonié (Voir sur ClinicalTrials)
juin 2023
janvier 2048
17 mai 2026
This is a multicentric, observational, retrospective and prospective study, aiming to
estimate the risk of cancer occurrence in subjects carrying a PTEN mutation, based on the
constitution of a national cohort.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT CURIE | 10/04/2025 13:12:23 | Contact (sur clinicalTrials) | |||
| CLCC RENE HUGUENIN INSTITUT CURIE | 10/04/2025 13:12:05 | Contact (sur clinicalTrials) | |||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP-HP - Hôpital Armand Trousseau-La Roche Guyon | Contact (sur clinicalTrials) | ||||
| AP-HP - Hôpital Avicenne | Contact (sur clinicalTrials) | ||||
| AP-HP - Hôpital Saint Antoine | Contact (sur clinicalTrials) | ||||
| CLCC INSTITUT CURIE | Contact (sur clinicalTrials) | ||||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| 20-CHU Montpellier - Montpellier - France | Contact (sur clinicalTrials) | ||||
| 24-CHU Poitiers - Poitiers - France | Contact (sur clinicalTrials) | ||||
| 26-Centre Eugène Marquis - Rennes - France | Contact (sur clinicalTrials) | ||||
| 27-CHU Rennes - Rennes - France | Contact (sur clinicalTrials) | ||||
| 36-CH Le Mans - Le Mans - France | Contact (sur clinicalTrials) | ||||
| 38-CHU Guadeloupe - Pointe à Pitre - France | Contact (sur clinicalTrials) | ||||
| 4-CHU Besançon - Besançon - France | Contact (sur clinicalTrials) | ||||
| 9-CH Métropole Savoie Chambéry - Chambéry - France | Contact (sur clinicalTrials) | ||||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| 10-CHU Colmar - Colmar - France | Contact (sur clinicalTrials) | ||||
| 11-CHU Dijon - Dijon - France | Contact (sur clinicalTrials) | ||||
| 12-CHU Grenoble - Grenoble - France | Contact (sur clinicalTrials) | ||||
| 13c-APH-HP Hôpital Salpétrière - Paris - France | Contact (sur clinicalTrials) | ||||
| 13e-AP-HP Hôpital Saint-Louis - Paris - France | Contact (sur clinicalTrials) | ||||
| 13f-AP-HP Hôpital Robert Debré - Paris - France | Contact (sur clinicalTrials) | ||||
| 15-Institut Gustave Roussy - Villejuif - France | Contact (sur clinicalTrials) | ||||
| 16-CHU Lille - Lille - France | Contact (sur clinicalTrials) | ||||
| 17-CHU Limoges - Limoges - France | Contact (sur clinicalTrials) | ||||
| 18a-Hospices Civils Lyon - Lyon Est - Lyon - France | Contact (sur clinicalTrials) | ||||
| 18b-Hospices Civils Lyon - Lyon Sud - Lyon - France | Contact (sur clinicalTrials) | ||||
| 19-AP-HM Hôpital de la Timone - Marseille - France | Contact (sur clinicalTrials) | ||||
| 1-CHU Amiens - Amiens - France | Contact (sur clinicalTrials) | ||||
| 21-CHU Nantes - Nantes - France | Contact (sur clinicalTrials) | ||||
| 22-CHU Nice - Nice - France | Contact (sur clinicalTrials) | ||||
| 23-CHU Nîmes - Nîmes - France | Contact (sur clinicalTrials) | ||||
| 25-Institut du Cancer Courlancy - Reims - France | Contact (sur clinicalTrials) | ||||
| 28-CHU Saint-Etienne - Saint-Etienne - France | Contact (sur clinicalTrials) | ||||
| 29-Institut Strauss - Strasbourg - France | Contact (sur clinicalTrials) | ||||
| 2-CHU Angers - Angers - France | Contact (sur clinicalTrials) | ||||
| 30-CHU Toulouse - Toulouse - France | Contact (sur clinicalTrials) | ||||
| 31-CHU Tours - Tours - France | Contact (sur clinicalTrials) | ||||
| 32-Centre Antoine Lacassagne - Nice - France | Contact (sur clinicalTrials) | ||||
| 33-Institut Paoli Calmettes - Marseille - France | Contact (sur clinicalTrials) | ||||
| 34-CH Valence - Valence - France | Contact (sur clinicalTrials) | ||||
| 35-CHU Rouen - Rouen - France | Contact (sur clinicalTrials) | ||||
| 37-CH Niort - Niort - France | Contact (sur clinicalTrials) | ||||
| 3-ICO Angers et Nantes - Angers - France | Contact (sur clinicalTrials) | ||||
| 40-CHU Troyes - Troyes - France | Contact (sur clinicalTrials) | ||||
| 5-CHU Bordeaux - Bordeaux - France | Contact (sur clinicalTrials) | ||||
| 6-Institut Bergonié - Bordeaux - France | Contact (sur clinicalTrials) | ||||
| 7-CHU Brest - Brest - France | Contact (sur clinicalTrials) | ||||
| 8-Centre François Baclesse - Caen - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
1. Male or female.
2. Adult or child without age limit.
3. Carrier of a constitutional or mosaic alteration of the PTEN gene established and/or
confirmed by the Institut Bergonié's genetics laboratory, following a request for
molecular diagnosis made between 1997 and 2027.
4. Participant informed of his genetic diagnosis.
5. Participant informed and not having expressed non-opposition to participate in the
research.
6. Participant affiliated to a French social security system in accordance with French
law on research involving the human person.
Exclusion Criteria:
1. Participant under guardianship or curatorship. Exception: a participant with autism
may be included in the study.
2. Persons deprived of their liberty by a judicial or administrative decision.
3. Persons under psychiatric care, persons admitted to a health or social establishment
for purposes other than research; Exception: a participant with autism may be
included in the study.